2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$2.07-$0.10 (-4.61%)
Price as of Jun 03, 2026 5:53 PM EDT- $441.9MMarket Cap
- 280.63%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$2.07-$0.10 (-4.61%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.17 | ||
Change | -$0.19 (-8.05%) | ||
Open | $2.37 | ||
High | $2.37 | ||
Low | $2.14 | ||
Previous Close | $2.36 | ||
Volume | 1,146,896 | ||
30-Day Average Volume | 823,762 | ||
1-Week Change | 0.00% | ||
1-Month Change | -6.06% | ||
1-Year Change | 280.63% | ||
3-Year Change | -34.24% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 180.4M | ||
Total Assets | $326.6M | ||
Market Cap | $441.9M | ||
Enterprise Value | $390.8M | ||
Period: QTR TTM FY | |||
Revenue | $109.2M | ||
Net Income | -$21.6M | ||
Free Cash Flow | -$25.8M | ||
EBIT | -$21.6M | ||
EBITDA | -$18.6M | ||
Net Working Capital | $125.5M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | -22 | ||
PEG | -0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue